The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) on Monday agreed to sponsor a new point-of-care anthrax diagnostic test.
The 18-month, $2.5 million agreement is through ASPR’s Biomedical Advanced Research and Development Authority.
The new test builds upon a similar version developed at the Centers for Disease Control and Prevention. Contemporary tests require sending samples to a laboratory for analysis, with results available in days. The new compact, portable test could potentially provide the doctors with results in as little as 15 minutes.
Having the results immediately available will help doctors make expedited decisions about the appropriate care and treatment for patients who may have been exposed to anthrax, particularly after a bioterrorism attack.
SRI International of Menlo Park, California, will conduct studies to ensure that the test accurately detects anthrax infections in blood samples. This process is needed to apply for clearance to market the device from the U.S. Food and Drug Administration. SRI International will work with DCB Diagnostics and Web Industries of Holliston, Massachusetts, on regulatory, design and manufacturing studies on the test.
The contract itself can be extended for three additional years, with an additional $7.8 million in funding.
Mere days after the Department of Homeland Security formed a new Artificial Intelligence (AI) Safety…
KBR will continue to provide life support, equipment readiness, training and supply chain solutions for…
In a bid to update federal spectrum and communications network policy, restore the auction authority…
As a new means to advise the Secretary of Homeland Security and stakeholders, and promote…
Members of Congress recently paraded a mix of recommended updates to benefit military service members…
The ByteDance-owned TikTok faces an uphill battle in the United States after President Joe Biden…
This website uses cookies.